ConductScience.org, home

Paper42479110

Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance.

Paul BM and 3 others. Inflammopharmacology, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance. Papers, record 42479110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42479110

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance.
PubMed
Journal
Inflammopharmacology
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Paul BMBenedict Mathews
2Kannan GGowtham
3Karuppasamy AArunachalam
4Thangaraj PParimelazhaganhttps://orcid.org/0000-0002-5874-8949

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ovarian NeoplasmsMajor topic
CytokinesMajor topic
InflammationMajor topic
Biological ProductsMajor topic
Senescence-Associated Secretory PhenotypeMajor topic
Humans
Female
Animals
Cellular Senescence
Drug Resistance, Neoplasm
Tumor Microenvironment
Epithelial-Mesenchymal Transition
Tumor Escape

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PHD-MEDHA-2023-10970Bayer FoundationPubMed
CMRG/3005/H3/2024/011Directorate of Technical Education - Chief Minister Research GrantPubMed
EEQ/2021/000203Science and Engineering Research BoardPubMed

Source PubMed

Download CSV of grants

References278

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127919958Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells.Anticancer Res2016https://conductscience.org/library/papers/27919958PubMed
237814270Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.Mol Cancer2023https://conductscience.org/library/papers/37814270PubMed
329173024Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9.Cancer Biol Ther2017https://conductscience.org/library/papers/29173024PubMed
424384374Liposomal siRNA nanocarriers for cancer therapy.Adv Drug Deliv Rev2014https://conductscience.org/library/papers/24384374PubMed
538267628The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.Nat Cancer2024https://conductscience.org/library/papers/38267628PubMed
637441528Antiaging effects of dietary supplements and natural products.Front Pharmacol2023https://conductscience.org/library/papers/37441528PubMed
733968932The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies.Front Cell Dev Biol2021https://conductscience.org/library/papers/33968932PubMed
834645978A highly annotated database of genes associated with platinum resistance in cancer.Oncogene2021https://conductscience.org/library/papers/34645978PubMed
940872567Network Pharmacology and Machine Learning Identify Flavonoids as Potential Senotherapeutics.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872567PubMed
1030988303Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells.Exp Mol Med2019https://conductscience.org/library/papers/30988303PubMed
1122313874Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.Semin Cancer Biol2012https://conductscience.org/library/papers/22313874PubMed
1236098323The costs and benefits of senotherapeutics for human health.Lancet Healthy Longev2022https://conductscience.org/library/papers/36098323PubMed
1338940746A second generation of senotherapies: the development of targeted senolytics, senoblockers and senoreversers for healthy ageing.Biochem Soc Trans2024https://conductscience.org/library/papers/38940746PubMed
1438604701Chemical Strategies for the Detection and Elimination of Senescent Cells.Acc Chem Res2024https://conductscience.org/library/papers/38604701PubMed
1538321020Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment.NPJ Aging2024https://conductscience.org/library/papers/38321020PubMed
1641513104Chlorogenic acid attenuates endometrial senescence via mTOR modulation: A combined network pharmacology, in vitro, and in vivo study.Biochem Pharmacol2026https://conductscience.org/library/papers/41513104PubMed
1731113465Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism.J Exp Clin Cancer Res2019https://conductscience.org/library/papers/31113465PubMed
1832555170Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies.Signal Transduct Target Ther2020https://conductscience.org/library/papers/32555170PubMed
1932849491Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.Front Immunol2020https://conductscience.org/library/papers/32849491PubMed
2037301862Discovery of senolytics using machine learning.Nat Commun2023https://conductscience.org/library/papers/37301862PubMed

See all 278 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ASPRV1151516PubTator's text mininghttps://conductscience.org/library/genes/151516NCBI Gene
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42479110

GET https://conductscience.org/api/papers/v1/42479110/references?page=2